Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

CONMED Company Profile (NASDAQ:CNMD)

Consensus Ratings for CONMED (NASDAQ:CNMD) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $47.67 (19.29% upside)

Analysts' Ratings History for CONMED (NASDAQ:CNMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/3/2014ZacksReiterated RatingNeutral -> Neutral$42.00ViewTweet This Rating  Share This Rating on StockTwits
7/18/2014ZacksReiterated RatingNeutral -> Neutral$44.00ViewTweet This Rating  Share This Rating on StockTwits
3/13/2014Ladenburg ThalmannUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
2/14/2014Summer StreetBoost Price Target$53.00ViewTweet This Rating  Share This Rating on StockTwits
2/14/2014Ladenburg ThalmannDowngradeBuy -> Neutral$42.00 -> $51.75ViewTweet This Rating  Share This Rating on StockTwits
2/11/2014Needham & Company LLCBoost Price TargetBuy$45.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2013Needham & Company LLCBoost Price Target$40.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Needham & Company LLCBoost Price TargetBuy$37.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2013Needham & Company LLCInitiated CoverageBuy$37.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2013Piper JaffrayBoost Price TargetNeutral$34.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2013Ladenburg ThalmannBoost Price TargetBuy$36.25 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/21/2012 forward)
Discuss CONMED